At Work With: Gary Pattison

Gary Pattison
Gary Pattison

GARY PATTISON
Group managing director, Ogilvy CommonHealth Australia 

What was your biggest break?

I fell into healthcare communications in 1997 after a long year spent in FMCG advertising in the UK.

What's the best and/or worst part of your job?

The best is playing our role in changing the future health outcomes for patients.

What's the view like from your office/work area?

We are based in Sydney with no view of the Opera House or the Harbour Bridge… but we have a great Aussie pub just a stone's throw from the office.

How long is a typical meeting with clients?

The best meetings are where we are thrown a challenge, find the killer insight or lever, then challenge and wrestle with the clients to get to a great place that leads to an amazing campaign or program. These last two or three hours… then we go to the pub.

What was your greatest professional challenge?

We brought a new model of medical communication to Australia in 2006.

Where will you be in five years?

Hopefully still involved with Ogilvy CommonHealth.

You must be a registered member of MMM to post a comment.
close

Next Article in Careers

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.